Buserelin
Buserelin Special Alerts GnRH Agonists: Canadian Labeling Updated to Include Increased Risk of Cardiovascular Disease in Males September 2011 Health Canada has issued notice to Canadian healthcare professionals and patients that the product labeling for Gonadotropin-Releasing Hormone (GnRH) agonists (eg, goserelin, leuprolide, buserelin, triptorelin, histrelin) has been updated with warnings…
View On WordPress











